Non-Opioid EXPAREL Shows Health, Economic Benefits
Pooled data show that EXPAREL® (bupivacaine liposome injectable suspension) slashes opioid consumption, risk of opioid- related side effects, length of postsurgery hospital stay, and cost.
Pooled data show that EXPAREL® (bupivacaine liposome injectable suspension) slashes opioid consumption, risk of opioid- related side effects, length of postsurgery hospital stay, and cost.
Establishment Labs Holdings Inc, a global medical technology company specializing in women’s health, announces the first U.S. breast augmentations using Motiva Implants.